Overview of AOD 9604

AOD 9604 (Anti-Obesity Drug 9604) is a modified fragment of the human growth hormone molecule, specifically representing amino acids 176-191 of the hGH C-terminus with additional modifications. Originally developed at Monash University in Australia in the 1990s, this 16-amino-acid peptide was engineered to isolate the fat-burning properties of growth hormone without the growth-promoting or insulin-related effects of full-length hGH.

Each vial available from SteroidsCanada.is contains 5mg of lyophilized AOD 9604, manufactured to rigorous pharmaceutical-grade standards and independently verified for purity exceeding 98% via HPLC analysis. This makes it an ideal choice for qualified researchers and laboratory professionals seeking dependable, high-quality peptides for hgh fragment research applications.

Mechanism of Action

Unlike traditional research compounds, AOD 9604 operates through an elegant biological mechanism — it mimics the way natural growth hormone regulates fat metabolism by stimulating lipolysis (fat breakdown) and inhibiting lipogenesis (fat creation). It achieves this primarily by activating beta-3 adrenergic receptors in adipose tissue. Critically, AOD 9604 does NOT affect IGF-1, blood glucose, or insulin sensitivity in research.

Key Research Applications

Product Specifications

Reconstitution Guidelines

AOD 9604 is supplied as a lyophilized (freeze-dried) powder that must be reconstituted with sterile bacteriostatic water (0.9% benzyl alcohol) before use in research applications. The recommended reconstitution volume for this vial is 2mL of bacteriostatic water, which yields a concentration suitable for precise research dosing.

Reconstitution Math — Quick Reference

If you add 2mL of bacteriostatic water to this 5mg vial:

On a standard 100 IU insulin syringe, here’s what each measurement equals for research reference:

Reconstitution Best Practices

• Use sterile bacteriostatic water (0.9% benzyl alcohol preservative)
• Add diluent slowly along the vial wall — never directly onto the peptide cake
• Gently swirl to dissolve — never shake the vial vigorously
• Allow the peptide to fully dissolve before drawing any dose
• Store reconstituted vials at 2–8°C (refrigerator)
• Use reconstituted peptide within 28–60 days depending on specific research requirements
• Always use sterile technique when drawing from the reconstituted vial

Research Protocol Guidelines

Research protocols commonly use 300-500mcg daily, often first thing in the morning to leverage natural low-insulin state.

Typical Research Timeline

• Week 1-2: Initial β3-receptor adaptation research
• Week 3-4: Peak lipolysis markers in research models
• Week 5-8: Sustained adipose tissue research phase
• Week 9-12: Extended research protocol applications

Individual research results vary based on protocol design, specific research objectives, and research model characteristics. The above timeline represents commonly observed patterns in published research literature.

Research Stacking Protocols

In research applications, AOD 9604 is often studied in combination with complementary research peptides to investigate pathway interactions. Common research combinations include:

• AOD 9604 + CJC-1295/Ipamorelin: Enhanced research combination
• AOD 9604 + BPC-157: Fat loss + healing research
• AOD 9604 + Tesamorelin: Targeted visceral research

Any research stacking protocol should be designed based on specific investigative objectives and informed by current scientific literature.

Why Choose SteroidsCanada.is?

• ✅ Pharmaceutical-grade AOD 9604 — lab tested for purity and potency
• ✅ Discreet shipping across Canada — plain outer packaging always
• ✅ Proper cold-chain handling to preserve peptide integrity
• ✅ Same-day dispatch on orders placed before 2PM EST
• ✅ COA available on request for every batch and SKU
• ✅ Secure payment — Interac E-Transfer and cryptocurrency
• ✅ Free shipping on all orders over $600 CAD
• ✅ Competitive Canadian pricing with no hidden fees
• ✅ Responsive customer service and reliable restocking